CD8A and neoplasm: Autochthonous KPC mice treated with CD11b agonist combined with anti-PD-1, anti-CTLA-4, and gemcitabine had significantly improved survival and increased intratumoral CD8 T cell infiltration, but the tumors were not rejected as seen with orthotopic tumor bearing mice (103).